Showing 5341-5350 of 20465 results for "".
- Nemolizumab Shows Durable Patient-Reported Benefits at 100 Weeks in PNhttps://reachmd.com/news/nemolizumab-shows-durable-patient-reported-benefits-at-100-weeks-in-pn/2484116/Long-term treatment with nemolizumab continues to deliver clinically meaningful improvements in itch, sleep, and quality of life for patients with prurigo nodularis (PN), according to interim results from the open-label extension (OLYMPIA-LTE) study presented by Dr
- New Review Highlights TWEAK/Fn14 Pathway's Potentialhttps://reachmd.com/news/new-review-highlights-tweakfn14-pathways-potential/2484097/A new review published in International Immunopharmacology explores the expanding role of the TWEAK/Fn14 signaling pathway in both skin disease pathogenesis and stem cell regulation, proposing its potential as a dual-purpose
- CHE Talk at Fall Clinical Highlights Precision Therapieshttps://reachmd.com/news/che-talk-at-fall-clinical-highlights-precision-therapies/2484094/With new FDA approvals, investigational therapies nearing the finish line, and a greater understanding of disease heterogeneity, chronic hand eczema (CHE) is increasingly viewed as a condition requiring individualized, mechanistically informed care, Alexandra Golant, MD, and Benjamin Ehst, MD, Ph
- Understanding Patient Priorities in Bladder Cancer Treatmenthttps://reachmd.com/news/understanding-patient-priorities-in-bladder-cancer-treatment/2484077/As treatment options for muscle-invasive bladder cancer (MIBC) continue to evolve—with immunotherapy and bladder-sparing protocols reshaping the landscape—a new study brings a crucial voice into the conversation: that of the patient.
- Emerging Biomarkers in Pediatric NAFLD: Beyond BMIhttps://reachmd.com/news/emerging-biomarkers-in-pediatric-nafld-beyond-bmi/2484084/In a prospective sample of 199 children, the triglyceride‑to‑HDL‑cholesterol ratio and the triglyceride‑glucose (TyG) index showed markedly higher sens
- Dr. Peter Lio Named Fall Clinical Educator of the Yearhttps://reachmd.com/news/dr-peter-lio-named-fall-clinical-educator-of-the-year/2484092/Peter Lio, MD, was presented with the Educator of the Year Award at the 2025 Fall Clinical Dermatology Conference. Dr. Lio is founding director of the Chicago Integrative Eczema Center and a member of Practical Dermatology’s Editorial Board. Dr. Lio spoke at the Fall Clinical Meetin
- New Deuruxolitinib Data Show It Meets 'The Need for Speed'https://reachmd.com/news/new-deuruxolitinib-data-show-it-meets-the-need-for-speed/2484089/Deuruxolitinib resulted in significant hair regrowth starting at Week 8, continually improving through Week 24, and the 8-mg and 12-mg BID doses showed significant efficacy vs placebo across subgroups, according to new data presented at the 2025 Fall Clinical Dermatology Conference. Other
- Seoul Virus Case in Germany Exposes Weaknesses in Zoonotic Disease Managementhttps://reachmd.com/news/seoul-virus-case-in-germany-exposes-weaknesses-in-zoonotic-disease-management/2484039/A human Seoul virus case in Germany has been genomically linked to a private rat-breeding facility, highlighting diagnostic and biosafety gaps with direct clinical and laboratory relevance. Evaluation of suspected hantavirus infection in the
- Arcutis Presents New ZORYVE Data in AD at Fall Clinical 2025https://reachmd.com/news/arcutis-presents-new-zoryve-data-in-ad-at-fall-clinical-2025/2484062/Updates and new data sets from the INTEGUMENT trial program, including new quality-of-life and efficacy data for ZORYVE® (roflumilast) cream in pediatric and adult patients with atopic dermatitis (AD), were featured at the 2025 Fall Clinical Dermatology Conference
- Phthalates May Heighten Cardiovascular Risk in Patients with CKDhttps://reachmd.com/news/phthalates-may-heighten-cardiovascular-risk-in-patients-with-ckd/2484033/In a new study that deepens concerns about environmental pollutants in vulnerable populations, researchers have identified a significant link between phthalate exposure and ca